Elevated plasma endothelin-1 and pulmonary arterial pressure in children exposed to air pollution

Environmental Health Perspectives

Volumn 115, Issue 8, 2007, Pages 1248-1253

  Calderón Garcidueñas, Lilian ^a,b   Vincent, Renaud ^c   Mora Tiscareño, Antonieta ^a   Franco Lira, Maricela ^d   Henríquez Roldán, Carlos ^e   Barragán Mejía, Gerardo ^a   Garrido García, Luis ^a   Camacho Reyes, Laura ^a   Valencia Salazar, Gildardo ^a   Paredes, Rogelio ^a   Romero, Lina ^a   Osnaya, Hector ^a   Villarreal Calderón, Rafael ^b   Torres Jardón, Ricardo ^f   Hazucha, Milan J ^g   Reed, William ^g,h  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b UNIVERSITY OF MONTANA   (United States)

^c HEALTH CANADA   (Canada)

^d Universidad del Ejercito y Fuerza Aerea   (Mexico)

^e UNIVERSIDAD DE VALPARAÍSO   (Chile)

^f UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h NONE   (United States)

Author keywords

Air pollution; Children; Endothelial dysfunction; Endothelin 1; Particulate matter; Pulmonary arterial pressure

Indexed keywords

ENDOTHELIN 1; OZONE;

ADOLESCENT; AIR POLLUTANT; AIR POLLUTION; AIR QUALITY; ARTICLE; CHILD; CHILD CARE; CHILD HEALTH; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; LEUKOCYTE COUNT; LUNG ARTERY PRESSURE; MALE; MEXICO; NORMAL HUMAN; PARTICULATE MATTER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; BLOOD PRESSURE; CITY; DRUG EFFECT; NEUTROPHIL; PATHOPHYSIOLOGY; PULMONARY ARTERY;

ANIMALIA;

ADOLESCENT; AIR POLLUTANTS; AIR POLLUTION; BLOOD PRESSURE; CHILD; CITIES; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIN-1; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MEXICO; NEUTROPHILS; OZONE; PARTICULATE MATTER; PULMONARY ARTERY;

EID: 34848829173     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9641     Document Type: Article

References (45)

1. Avogaro A, De Kreutzenberg SV. 2005. Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta 360:9-26.
2. Bonner JC, Rice AB, Lindroos PM, O'Brien PO, Dreher KL, Rosas I, et al. 1998. Induction of the lung myofibroblast PDGF receptor system by urban ambient particles from Mexico City. Am J Respir Cell Molec Biol 19:672-680.
3. Bouthillier L, Vincent R, Goegan P, Adamson IY, Bjarnason S, Stewart M, et al. 1998. Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am J Physiol 153:1873-1884.
4. Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. 2002. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 105:1534-1536.
5. Calderón-Garcidueñas L, Franco-Lira M, Torres-Jardón R, Henríquez-Roldán C, Barragán-Mejía G, Valencia-Salazar G, et al. 2007. Pediatric respiratory and systemic effects of chronic air pollution exposure: nose, lung, heart and brain pathology. Toxicol Pathol 35:154-162.
6. Calderón-Garcidueñas L, Gambling TM, Acuña H, Garcia R, Osnaya N, Monroy S, et al. 2001a. Canines as sentinel species for assessing chronic exposures to air pollutants: part2. Cardiac pathology. Toxicol Sci 61:356-367.
7. Calderón-Garcidueñas L, Mora-Tiscareño A, Fordham LA, Chung CJ, Garcia R, Osnaya N, et al. 2001b. Canines as sentinel species for assessing chronic exposures to air pollutants: Part 1. Respiratory pathology. Toxicol Sci 61:342-355.
8. Calderón-Garcidueñas L, Mora-Tiscareño A, Fordham LA, Chung CJ, Valencia-Salazar G, Gómez S, et al. 2006. Lung radiology and pulmonary function of children chronically exposed to air pollution. Environ Health Perspect 114:1432-1437.
9. Calderón-Garcidueñas L, Mora-Tiscareño A, Fordham LA, Valencia-Salazar G, Chung CJ, Rodríguez-Alcaraz A, et al. 2003. Respiratory damage in children exposed to urban pollution. Pediatr Pulmonol 36:148-161.
10. Calderón-Garcidueñas L, Romero L, Barragán G, Reed W. 2005. Upregulation of plasma endothelin-1 (ET-1) levels and CD14 expression on peripheral blood monocytes in healthy children exposed to urban air pollution [Abstract]. FASEB J 19:A489.
11. Charron P, Tesson F, Poirier O, Nicaud V, Peuchmaurd M, Tiret L, et al. 1999. Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group. Eur Heart J 20:1587-1591.
12. Chemla O, Castelain V, Humbert M, Hebert JL, Simonneau G, Lecarpentier Y, et al. 2004. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 126:1313-1317.
13. Dong Y, Wang X, Zhu H, Treiber FA, Snieder H. 2004. Endothelin-1 gene and progression of blood pressure and left ventricular mass: longitudinal findings in youth. Hypertension 44:884-890.
14. Douthwaite JA, Lees DM, Corder R. 2003. A role for increased mRNA stability in the induction of endothelin-1 synthesis by lipopolysaccharide. Biochem Pharmacol 66:589-594.
15. Endemann DH, Schiffrin EL. 2004. Endothelial dysfunction. J Am Soc Nephrol 15:1983-1992.
16. Fratz S, Geiger R, Kresse H, Roemer G, Hennig M, Sebening W, et al. 2003. Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance. J Thorac Cardiovasc Surg 126:1724-1729.
17. Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, et al. 2004. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243-2278.
18. Giannessi D, Del Ry S, Andreassi MG, Nardini V, Pelosi G, Colombo MG, et al. 1999. High density of endothelin binding sites in the hearts of infants and children. Life Sci 64:697-705.
19. Hocher B, Schwarz A, Fagan KA, Thone-Reineke C, El Hag K, Kusserow H, et al. 2000. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Cell Molec Biol 23:19-26.
20. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al. 2004. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43:13S-24S.
21. Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM. 2001. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 104:864-869.
22. Immervoll T, Loesgen S, Dutsch G, Gohlke H, Herbon N, Klugbauar S, et al. 2001. Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes. Hum Mutat 18:327-336.
23. Jin JJ, Nakura J, Wu Z, Yamamoto M, Abe M, Tabara Y, et al. 2003. Association of endothelin-1 gene variant with hypertension. Hypertension 41:163-167.
24. Kaehler J, Sill B, Koester R, Mittmann C, Orzechowski HD, Muenzel T, et al. 2002. Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species. Clin Sci (Lond) 103(suppl 48):176S-178S.
25. 2.5) in rats with acute myocardial infarction. Cardiovasc Toxicol 2:253-261.
26. Künzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, et al. 2005. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect 113:201-206.
27. Laight DW, Carrier MJ, Anggard EE. 2000. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 47:457-464.
28. Lerman A, Holmes DR, Jr., Bell MR, Garratt KN, Nishimura RA, Burnett JC, Jr. 1995. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92:2426-2431.
29. López FA, Riesco A, Espinosa G, Digiuni E, Cernadas MR, Alvarez V, et al. 1993. Effect of endothelin-1 on neutrophil adhesion to endothelial calls and perfused heart. Circulation 88:1166-1171.
30. Luscher TF, Barton M. 2000. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102:2434-2440.
31. Mathew R, Huang J, Shah M, Patel K, Gewitz M, Sehgal PB. 2004. Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 110:1499-1506.
32. Migneault A, Sauvageau S, Villeneuve L, Thorin E, Fournier A, Leblanc N, et al. 2005. Chronically elevated endothelin levels reduce pulmonary vascular reactivity to nitric oxide. Am J Respir Crit Care Med 171:506-513.
33. Murray DB, Gardner JO, Brower GL, Janicki JS. 2004. Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats. Am J Physiol Heart Circ Physiol 287:H2295-H2299.
34. Osornio-Vargas AR, Bonner JC, Alfaro-Moreno E, Martínez L, García-Cuellar C, Ponce-do-León-Rosales S, et al. 2003. Proinflammatory and cytotoxic effects of Mexico City air pollution particulate matter in vitro are dependent on particle size and composition. Environ Health Perspect 111:1289-1293.
35. Rage GB, Baumgardner D, Castro T, Martínez-Arroyo A, Navarro-González R. 2001. Mexico City air quality: a qualitative review of gas and aerosol measurements (1960-2000). Atmos Environ 35:4041-4058.
36. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. 1989. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358-367.
37. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. 2004. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43:5S-12S.
38. Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, et al. 2005. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA 294:3003-3010.
39. Suwa T, Hogg JC, Quinlan KB, Ohgami A, Vincent R, van Eeden SF. 2002. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 39:935-942.
40. Thomson E, Goegen P, Kumarathasan P, Vincent R. 2004. Air pollutants increase gene expression of the vasoconstrictor endothelin-1 in the lungs. Biochim Biophys Acta 1689:75-82.
41. Thomson E, Kumarathasan P, Goegan P, Aubin RA, Vincent R. 2005. Differential regulation of the lung endothelin system by urban particulate matter and ozone. Toxicol Sci 88:103-113.
42. Villarreal-Calderón A, Acuña H, Villarreal-Calderón J, Garduno M, Henríquez-Roldán CF, Calderón-Garcidueñas L, et al. 2002. Assessment of physical education time and after-school outdoor time in elementary and middle school students in south Mexico City: the dilemma between physical fitness and the adverse health effects of outdoor pollutant exposure. Arch Environ Health 57:450-460.
43. Vincent R, Kumarathasan P, Goegan P, Bjarnasan SG, Guenette J, Berube D, et al, 2001a. Inhalation toxicology of urban ambient particulate matter: acute cardiovascular effects in rats. Res Rep Health Eff Inst 5-54.
44. 2.5) causes elevations of the plasma vasopeptides endothelin(ET)-1 and ET-3 in humans [Abstract]. Am J Respir Crit Care Med 163:A313.
45. Yamaguchi T, Murata Y, Fujiyoshi Y, Doi T. 2003. Regulated interaction of endothelin B receptor with caveolin-1. Eur J Biochem 270:1816-1827.